These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30564304)

  • 1. Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.
    Hanson K; Robinson SD; Al-Yousuf K; Hendry AE; Sexton DW; Sherwood V; Wheeler GN
    Oncotarget; 2018 Nov; 9(93):36645. PubMed ID: 30564304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.
    Hanson K; Robinson SD; Al-Yousuf K; Hendry AE; Sexton DW; Sherwood V; Wheeler GN
    Oncotarget; 2018 Jan; 9(3):3815-3829. PubMed ID: 29423085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
    Marciel MP; Khadka VS; Deng Y; Kilicaslan P; Pham A; Bertino P; Lee K; Chen S; Glibetic N; Hoffmann FW; Matter ML; Hoffmann PR
    Oncotarget; 2018 Jul; 9(56):30937. PubMed ID: 30112120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
    Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
    Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.
    Romano E; Rufo N; Korf H; Mathieu C; Garg AD; Agostinis P
    Oncotarget; 2018 Dec; 9(97):37076. PubMed ID: 30651937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.
    Bjoern J; Lyngaa R; Andersen R; Hölmich LR; Hadrup SR; Donia M; Svane IM
    Oncotarget; 2018 Nov; 9(88):35870. PubMed ID: 30533201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance.
    Martin CA; Cullinane C; Kirby L; Abuhammad S; Lelliott EJ; Waldeck K; Young RJ; Brajanovski N; Cameron DP; Walker R; Sanij E; Poortinga G; Hannan RD; Pearson RB; Hicks RJ; McArthur GA; Sheppard KE
    Int J Cancer; 2018 May; 142(10):2139-2152. PubMed ID: 29243224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes.
    Hakkim FL; Bakshi HA; Khan S; Nasef MM; Farzand R; Sam S; Rashan L; Al-Baloshi MS; Abdo Hasson SSA; Jabri AA; McCarron PA; Tambuwala MM
    Oncotarget; 2020 Jun; 11(23):2259-2261. PubMed ID: 32577169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
    Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
    Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.
    Hu K; Babapoor-Farrokhran S; Rodrigues M; Deshpande M; Puchner B; Kashiwabuchi F; Hassan SJ; Asnaghi L; Handa JT; Merbs S; Eberhart CG; Semenza GL; Montaner S; Sodhi A
    Oncotarget; 2021 Mar; 12(5):519-520. PubMed ID: 33747364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Cutaneous melanoma primary site is linked to nevus density.
    Martin-Gorgojo A; Llinares M; Virós A; Requena C; Garcia-Casado Z; Traves V; Kumar R; Nagore E
    Oncotarget; 2018 Dec; 9(95):36816. PubMed ID: 30613369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
    Raninga PV; Trapani GD; Vuckovic S; Bhatia M; Tonissen KF
    Oncotarget; 2021 Apr; 12(9):948-949. PubMed ID: 33953848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development.
    Molina L; Yang H; Michael AOA; Oertel M; Bell A; Singh S; Chen X; Tao J; Monga SP
    Oncotarget; 2019 Sep; 10(54):5670. PubMed ID: 31645895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models.
    Feldman T; Grossman-Haham I; Elkis Y; Vilela P; Moskovits N; Barshack I; Salame TM; Fass D; Ilani T
    Oncotarget; 2020 Oct; 11(40):3687. PubMed ID: 33088428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma.
    Bharadwaj U; Eckols TK; Xu X; Kasembeli MM; Chen Y; Adachi M; Song Y; Mo Q; Lai SY; Tweardy DJ
    Oncotarget; 2019 Feb; 10(16):1603. PubMed ID: 30899429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction:
    Terzo EA; Lim AR; Chytil A; Chiang YC; Farmer L; Gessner KH; Walker CL; Jansen VM; Rathmell WK
    Oncotarget; 2019 Oct; 10(59):6391-6392. PubMed ID: 31695846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum:
    Smith AM; Zhang CRC; Cristino AS; Grady JP; Fink JL; Moore AS
    Oncotarget; 2020 Jan; 11(3):305. PubMed ID: 32076493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition.
    Najem A; Krayem M; Salès F; Hussein N; Badran B; Robert C; Awada A; Journe F; Ghanem GE
    Eur J Cancer; 2017 Sep; 83():154-165. PubMed ID: 28738256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Inhibition of neddylation regulates dendritic cell functions
    Cheng M; Hu S; Wang Z; Pei Y; Fan R; Liu X; Wang L; Zhou J; Zheng S; Zhang T; Lin Y; Zhang M; Tao R; Zhong J
    Oncotarget; 2018 Dec; 9(99):37343. PubMed ID: 30647874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.
    Sun H; Lin DC; Guo X; Masouleh BK; Gery S; Cao Q; Alkan S; Ikezoe T; Akiba C; Paquette R; Chien W; Müller-Tidow C; Jing Y; Agelopoulos K; Müschen M; Koeffler HP
    Oncotarget; 2017 Sep; 8(38):64651. PubMed ID: 28969101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.